Summary
Hepatocellular carcinoma (HCC) was treated with transcatheter arterial chemoembolization (TACE) in a sample of 129 patients. The cumulative survival rate was 49% at 1 year and 22% at 2 years. The median survival time was 11.9 months. The survival rates at 1 year of 84 patients in Child's group A and 27 in Child's group B were 56% and 40%; out of 52 HCC patients with portal vein patent and 77 with portal vein invasion 75% and 40% survived, and the 1-year survival rates for 33 HCC patients with capsule intact, 14 with caspule broken and 82 with no capsule were 85%, 65% and 40% respectively. From the above results there were statistically significant differences in survival time in those with good clinical performance status by Child's classification, those showing patency of the portal vein and those where the capsule was present. Therefore, we would like to recommend, TACE of HCC in well-selected patients presenting with good clinical status, patency of the portal vein and without broken capsule, in order to achieve better clinical results.
Similar content being viewed by others
References
Chen CM, Liu TJ, Luiway, Peng FK, Lai KH, Lee SD, Yang CF, Chiang JH (1984) Chemotherapy of hepatic tumor: intraarterial infusion chemotherapy for treating hepatocellular carcinoma with FAM regimen. Excerpta Medica, Tokyo, p 34
Child CG, Turcatte JG (1964) Surgery and portal hypertension. In: Child CG (ed) The liver and portal hypertension. W. B. Saunders Co, Philadelphia, p 50
Department of Health, Executive Yuan, R.O.C. (1983) Cancer Registry Annual Report in Taiwan area. 1981
Falkson G, Moertel GC, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial. Cancer 42: 2149
Falkson G, Macintyre MJ, Moertel GC, Johnson AL, Scherman CR (1984) Primary liver cancer. An eastern cooperative oncology group trial. Cancer 54: 970
Hsu HC, Lin WSJ, Tsai MJ (1983) Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With Special reference to types and localization of HBsAg in the tumor cells. Cancer 52: 1825
Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, Pao CC (1986) Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 90: 263
Lin DY, Liaw YF, Lee TY, Lai CM (1988) Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial. Gastroenterology (in press)
Liver Cancer Study Group of Japan (1979) Survey and follow up study of primary liver cancer in Japan. Report 4. Acta Hepatol Jpn (Tokyo) 20: 433
Nagasue M, Yukaya H, Hamada T, Hirose S, Kanashima R, Ionkuchi K (1984) The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 54: 1461
Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M (1983) Transcatheter embolization of hepatocellular carcinoma. Assessment of efficacy in cases of resection following embolization. Radiology 147: 401
Olweny CM (1975) Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer 36: 1250
Sato Y, Fujiwara K, Ogata I, Ohta Y, Hayashi S, Oka Y, Furui S, Oka H (1985) Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer 55: 2822
Sciarrino E, Simonetti GR, Moli LS, Pagliaro L (1985) Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer 56: 2751
Sheu JC, Sung JL, Chen DS, Yu JY, Wang TH, Su CT, Tsang YM (1984) Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instruments. Radiology 150: 797
Sheu JC, Sung JL, Chen DS, Lai MY, Wang TH, Yu JY, Yang PM, Chuang CN, Yang PC, Lee CS, Hsu HC, How SW (1985) Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer 56: 660
Yamada S, Sato M, Kawabata M, Nakatsuka N, Nakamua K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397
Yang PM, Chuang JN, Chen DS, Lai MY, Shen JC, Wang CY, Wang TH, Yu JY, Sung JL (1984) Chemotherapy or hepatocellular carcinoma with adriamycin alone and with FAN regimen. Excepta Medica, Tokyo, p 41
Vincent PC, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140: 51
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, CF., Ho, YZ., Chang, JM. et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 23 (Suppl 1), S26–S28 (1989). https://doi.org/10.1007/BF00647234
Issue Date:
DOI: https://doi.org/10.1007/BF00647234